34
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Rapid Improvement in Fasting Lipids and Hepatic Toxicity After Switching From Didanosine/Lamivudine to Tenofovir/Emtricitabine in Patients With Toxicity Attributable to Didanosine

, , , , , , & show all
Pages 118-120 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maxwell O Akanbi, Kimberly Scarsi, Babafemi Taiwo & Robert L Murphy. (2012) Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV Infection. Expert Opinion on Pharmacotherapy 13:1, pages 65-79.
Read now

Articles from other publishers (4)

Jennillee Wallace, Hemil Gonzalez, Reshma Rajan, Srinivas D. Narasipura, Amber K. Virdi, Arnold Z. Olali, Ankur Naqib, Zarema Arbieva, Mark Maienschein-Cline & Lena Al-Harthi. (2022) Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages. Antimicrobial Agents and Chemotherapy 66:4.
Crossref
José R. Santos, María Saumoy, Adrian Curran, Isabel Bravo, Josep M. Llibre, Jordi Navarro, Carla Estany, Daniel Podzamczer, Esteban Ribera, Eugènia Negredo, Bonaventura Clotet & Roger Paredes. (2015) The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases 61:3, pages 403-408.
Crossref
. (2014) International Congress of Drug Therapy in HIV Infection 2-6 November 2014, Glasgow, UK. Journal of the International AIDS Society 17, pages 19856.
Crossref
José Ramón Santos, María Saumoy, Adrian Curran, Isabel Bravo, Jordi Navarro, Carla Estany, Daniel Podzamczer, Esteban Ribera, Eugenia Negredo, Bonaventura Clotet & Roger Paredes. (2014) Randomized, crossover, double‐blind, placebo‐controlled trial to assess the lipid lowering effect of co‐formulated TDF/FTC. Journal of the International AIDS Society 17:4S3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.